Investor Relations

We are a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders. We improve compliance, absorption, and more with our proprietary drug delivery technology.

Stock Information

NASDAQLPCN
$2.23
NASDAQLPCN
Open
$2.18
Change
-$0.05 (-2.19%)
Day's Range
$2.16 - $2.42
52-Week Range
$0.31 - $2.43
Volume
5.3M
Market Cap
$146.5M